Bjørn-Tore Gjertsen

35PUBLICATIONS
130CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyRegenerative medicine (incl. stem cells)Oral implantologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 15, 2026
Phase I, open-label, multi-center dose-finding and expansion study to investigate the safety, tolerability, and preliminary efficacy of CR-001 (5-FU-miR-15a) in patients with acute myeloid leukemia.

|Jun 08, 2026
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

|Sep 03, 2025
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial.

Tim R Mocking, Lukas H Haaksma, Tom Reuvekamp

|Aug 22, 2025
Bone Augmentation of Atrophic Alveolar Ridges Using a Synthetic Bone Substitute With Mesenchymal Stem Cells: A Randomized, Controlled Clinical Trial.

Mariano Sanz, Cecilie Gjerde, Bjørn Tore Gjertsen

|Jul 02, 2025
CML stem cells and their interactions and adaptations to tyrosine kinase inhibitors.

Stein-Erik Gullaksen, Maria Omsland, Mathias Brevik

|May 01, 2025
Temperature as a Key Modulator: Investigating Phosphorylation Patterns of p.Asn666 PDGFRB Variants and Their Role in Downstream Signaling.

Titas Gladkauskas, Ileana Cristea, Roya Mehrasa

Pageof 6

Frequent Collaborators

5 joint publications

Markus Manz

4 joint publications

Kimmo Porkka

4 joint publications

Stein-Erik Gullaksen

4 joint publications

Vibeke Andresen